Literature DB >> 6607798

Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes.

R J ten Berge, H P Sauerwein, S L Yong, P T Schellekens.   

Abstract

Oral administration of prednisolone (in single doses of 10, 30, or 60 mg) to healthy volunteers was found to affect the T lymphocytes in the blood with regard to binding of monoclonal antibodies and lactate dehydrogenase isoenzyme pattern. The findings indicate that these effects are dependent on the dose of the drug and the time after the administration of the drug. Prednisolone induces a T lymphocytopenia in the peripheral blood that affects OKT4-positive lymphocytes more than OKT8-positive lymphocytes, resulting in a slight decrease in the ratio OKT4/OKT8. Moreover, the lactate dehydrogenase isoenzyme pattern changes, resulting in a decrease of the H/M ratio of this enzyme. The proliferative responses of peripheral blood lymphocytes are not affected after a single dose of 10 mg. However, after administration of either 30 or 60 mg of prednisolone, the proliferative responses are decreased to a different extent, depending on the stimulus used. In vitro experiments are presented showing that any effect of prednisolone on nonstimulated lymphocytes is reversible. Based on the observed changes in OKT pattern and lactate dehydrogenase isoenzyme profile of the T lymphocytes induced by administration of prednisolone, it is concluded that the drug induces a temporary depletion from the peripheral blood, preferentially of high-reactive T lymphocytes. As a consequence, the peripheral blood compartment is enriched for T lymphocytes with a low H/M ratio of lactate dehydrogenase isoenzymes, known to be less reactive to proliferative stimuli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607798     DOI: 10.1016/0090-1229(84)90010-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

1.  Lactate dehydrogenase levels during MACOP-B chemotherapy for non-Hodgkin's lymphoma.

Authors:  B McAdam; T Smith; W C Love; M Murphy; P A Daly
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

2.  The in situ cellular immune response in acute herpes simplex encephalitis.

Authors:  R A Sobel; A B Collins; R B Colvin; A K Bhan
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

3.  Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency.

Authors:  R J ten Berge; P T Schellekens; A Budding-Koppenol; L J Dooren; J M Vossen
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

4.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G D Pountain; M T Keogan; D L Brown; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

5.  Hypogammaglobulinaemia associated with long term, low dose steroid therapy.

Authors:  R J Lee; A C Fay
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

6.  Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.

Authors:  M H Magee; R A Blum; C D Lates; W J Jusko
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

7.  Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

Authors:  Mindy He Magee; Robert A Blum; Christian D Lates; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

8.  [The change of T lymphocyte subpopulations, interleukin-2 receptor and HLA-DR antigen in lupus nephritis patients].

Authors:  L Yu; J Z Tang; J L Zhang
Journal:  J Tongji Med Univ       Date:  1993

9.  Influence of prolonged neuropsychological testing on immunoregulatory cells and hormonal parameters in patients with systemic lupus erythematosus.

Authors:  H Hinrichsen; J Barth; M Rückemann; R Ferstl; W Kirch
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets.

Authors:  G D Pountain; M T Keogan; B L Hazleman; D L Brown
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.